LEADER 01455nam  2200457   450 
001 9910794748503321
005 20230808205614.0
010   $a1-68108-247-0
035   $a(CKB)4340000000024090
035   $a(MiAaPQ)EBC4768336
035   $a(EXLCZ)994340000000024090
100   $a20161223h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aFrontiers in clinical drug research -- diabetes and obesity$hVolume 3 /$feditor, Atta-ur-Rahman, FRS
210  1$aSharjah, United Arab Emirates :$cBentham Books,$d2016.
210  4$dİ2016
215   $a1 online resource (257 pages) $cillustrations, tables
225 0 $aFrontiers in Clinical Drug Research -- Diabetes and Obesity,$x2352-3220 ;$vVolume 3
311   $a1-68108-248-9 
320   $aIncludes bibliographical references at the end of each chapters and index.
606   $aDiabetes
606   $aDiabetes$xAlternative treatment
606   $aObesity
606   $aObesity$vCongresses
615  0$aDiabetes.
615  0$aDiabetes$xAlternative treatment.
615  0$aObesity.
615  0$aObesity
676   $a616.462
702   $aAtta-ur-Rahman
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910794748503321
996   $aFrontiers in clinical drug research -- diabetes and obesity$93711128
997   $aUNINA